| 1 | [SID103163065] | Active | IC50 | 0.169 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | 0.169 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 2 | [SID103163065] | Active | IC50 | 0.169 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | 0.169 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 3 | [SID103163065] | Active | IC50 | 2.04 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | 2.04 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 4 | [SID103163065] | Active | IC50 | 2.04 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | 2.04 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 5 | [SID103163065] | Active | IC50 | 2.04 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | 2.04 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 6 | [SID103163065] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID103163065] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID103163065] | Active | Potency | 11.5821 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID103163065] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis [AID588726, Type: screening] | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis | | AID | 588726 | | BioAssay type | screening | | Target | Probable fructose-bisphosphate aldolase Fba [Mycobacterium tuberculosis H37Rv] [gi:15607504] | | PubMed | | | Data Table |  |
|
| 10 | [SID103163065] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588792, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588792 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 11 | [SID103163065] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID588794, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 588794 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 12 | [SID103163065] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). [AID588824, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). | | AID | 588824 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 13 | [SID103163065] | Active | | | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen [AID686949, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 686949 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 14 | [SID103163065] | Active | | | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen [AID686949, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 686949 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 15 | [SID103163065] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 16 | [SID103163065] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 17 | [SID103163065] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 18 | [SID103163065] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 19 | [SID103163065] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 20 | [SID103163065] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 21 | [SID103163065] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 22 | [SID103163065] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) [AID651957, Type: screening] | NCOA2 gene product [Homo sapiens] [gi:5729858] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2) | | AID | 651957 | | BioAssay type | screening | | Target | NCOA2 gene product [Homo sapiens] [gi:5729858] | | PubMed | | | Data Table |  |
|
| 23 | [SID103163065] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 24 | [SID103163065] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 25 | [SID103163065] | Active | | | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence [AID686952, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence | | AID | 686952 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID103163065] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 27 | [SID103163065] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 28 | [SID103163065] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 29 | [SID103163065] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 30 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_2, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 31 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_2, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 32 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_3, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 33 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_3, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 34 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_5, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 35 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_5, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 36 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_6, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 37 | [SID103163065] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_6, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 38 | [SID103163065] | Inactive | IC50 | 79 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 39 | [SID103163065] | Inactive | IC50 | 79 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 40 | [SID103163065] | Inactive | IC50 | 79 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | IC50 | 79 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 41 | [SID103163065] | Inactive | | | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate [AID651958, Type: screening] | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate | | AID | 651958 | | BioAssay type | screening | | Target | putative polyprotein [Crimean-Congo hemorrhagic fever virus] [gi:76364066] | | PubMed | | | Data Table |  |
|
| 42 | [SID103163065] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) [AID624268, Type: screening] | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS) | | AID | 624268 | | BioAssay type | screening | | Target | methionyl-tRNA synthetase [Trypanosoma brucei brucei strain 927/4 GUTat10.1] [gi:71746704] | | PubMed | | | Data Table |  |
|
| 43 | [SID103163065] | Inactive | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 44 | [SID103163065] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set [AID588499, Type: Literature] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | | AID | 588499 | | BioAssay type | Literature | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | 16604538 | | Data Table |  |
|
| 45 | [SID103163065] | Inactive | | | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity [AID602481, Type: screening] | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602481 | | BioAssay type | screening | | Target | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] | | PubMed | | | Data Table |  |
|
| 46 | [SID103163065] | Inactive | | | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity [AID588549, Type: screening] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588549 | | BioAssay type | screening | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 47 | [SID103163065] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 48 | [SID103163065] | Inactive | | | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity [AID602329, Type: screening] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602329 | | BioAssay type | screening | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 49 | [SID103163065] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 50 | [SID103163065] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103163065 | | CID | 49795456 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|